Cardiol Therapeutics Inc (TSX: CRDL )
2.680
-0.080
(-2.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Cardiol Therapeutics IncVia TheNewswire.com
Exposures
Product Safety
![]() Via Newsfile
![]()
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
February 15, 2024
Via Newsfile
Exposures
Product Safety
![]() Via Benzinga
Via Newsfile
Cardiol Therapeutics On Track To Provide New Standard Of Care For Cardiovascular Diseases ($CRDL)
October 10, 2023
Via AB Newswire
Topics
Stocks
Exposures
US Equities
Via Newsfile
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
![]()
Why Orphan Drug Designation Offers Several Benefits
May 18, 2022
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|